Dec 19, 2016
Analyst Activity – Piper Jaffray Cos. Initiates Coverage On Recro Pharma (NASDAQ:REPH) With a Overweight
Analyst Activity – Piper Jaffray Cos. Initiates Coverage On Recro Pharma (NASDAQ:REPH) With a Overweight
Analyst Ratings For Recro Pharma (NASDAQ:REPH) Today, Piper Jaffray Cos. initiated coverage on Recro Pharma (NASDAQ:REPH) with a Overweight with a price target of $12.00. There are 6 buy ratings on the stock. The current consensus rating on Recro Pharma (NASDAQ:REPH) is Buy (Score: 3.00) with a consensus target price of $19.67 per share, a potential 187.52% upside. Some recent analyst ratings…
View On WordPress